Advertisement
Screener

SALIX PHARMACEUTICALS LTD Depreciation and Amortization

SALIX PHARMACEUTICALS LTD Depreciation and Amortization

SALIX PHARMACEUTICALS LTD reported Depreciation and Amortization of $226.27 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-02.

Discontinued › Cash Flow › Operating Activities

us-gaap:DepreciationDepletionAndAmortization · last filed 2015-03-02

  • SALIX PHARMACEUTICALS LTD depreciation, depletion and amortization for the quarter ending 2014-12-31 was $57.61M, a 337.48% increase year-over-year.
  • SALIX PHARMACEUTICALS LTD depreciation, depletion and amortization for the quarter ending 2014-09-30 was $56.50M, a 331.84% increase year-over-year.
  • SALIX PHARMACEUTICALS LTD depreciation, depletion and amortization for the quarter ending 2014-06-30 was $56.09M, a 333.10% increase year-over-year.
  • SALIX PHARMACEUTICALS LTD depreciation, depletion and amortization for the quarter ending 2014-03-31 was $56.07M, a 333.66% increase year-over-year.
  • SALIX PHARMACEUTICALS LTD depreciation, depletion and amortization for fiscal 2014 was $226.27M, a 334.03% increase from fiscal 2013.
  • SALIX PHARMACEUTICALS LTD depreciation, depletion and amortization for fiscal 2013 was $52.13M, a 0.03% decline from fiscal 2012.
  • SALIX PHARMACEUTICALS LTD depreciation, depletion and amortization for fiscal 2012 was $52.15M, a 242.03% increase from fiscal 2011.
  • SALIX PHARMACEUTICALS LTD depreciation, depletion and amortization for fiscal 2011 was $15.25M, a 14.51% increase from fiscal 2010.
Period endDepreciation, Depletion and Amortization 3 monthDepreciation, Depletion and Amortization 3 month as first filedDepreciation, Depletion and Amortization 6 monthDepreciation, Depletion and Amortization 6 month as first filedDepreciation, Depletion and Amortization 9 monthDepreciation, Depletion and Amortization 9 month as first filedDepreciation, Depletion and Amortization 12 month
2014-12-31$57.61M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-03-02
$114.11M
derived: sum of 2 quarters · filed 2015-03-02
$170.20M
derived: sum of 3 quarters · filed 2015-03-02
$226.27M
10-K · filed 2015-03-02
2014-09-30$56.50M
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2015-03-02
$112.60M
derived: sum of 2 quarters · filed 2015-03-02
$168.66M
10-Q/A · filed 2015-03-02
$171.66M
10-Q · filed 2014-11-07
$181.83M
derived: sum of 4 quarters · filed 2015-03-02
2014-06-30$56.09M
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2015-03-02
$112.16M
10-Q/A · filed 2015-03-02
$114.16M
10-Q · filed 2014-08-08
$125.33M
derived: sum of 3 quarters · filed 2015-03-02
$138.41M
derived: sum of 4 quarters · filed 2015-03-02
2014-03-31$56.07M
10-Q/A · filed 2015-03-02
$57.07M
10-Q · filed 2014-05-09
$69.24M
derived: sum of 2 quarters · filed 2015-03-02
$82.32M
derived: sum of 3 quarters · filed 2015-03-02
$95.27M
derived: sum of 4 quarters · filed 2015-03-02
2013-12-31$13.17M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-03-02
$26.25M
derived: sum of 2 quarters · filed 2015-03-02
$39.20M
derived: sum of 3 quarters · filed 2015-03-02
$52.13M
10-K · filed 2015-03-02
2013-09-30$13.08M
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2015-03-02
$26.04M
derived: sum of 2 quarters · filed 2015-03-02
$38.97M
10-Q/A · filed 2015-03-02
$52.00M
derived: sum of 4 quarters · filed 2015-03-02
2013-06-30$12.95M
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2015-03-02
$25.88M
10-Q/A · filed 2015-03-02
$38.91M
derived: sum of 3 quarters · filed 2015-03-02
$51.95M
derived: sum of 4 quarters · filed 2015-03-02
2013-03-31$12.93M
10-Q/A · filed 2015-03-02
$25.96M
derived: sum of 2 quarters · filed 2015-03-02
$39.00M
derived: sum of 3 quarters · filed 2015-03-02
$52.01M
derived: sum of 4 quarters · filed 2015-03-02
2012-12-31$13.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
$26.07M
derived: sum of 2 quarters · filed 2015-03-02
$39.08M
derived: sum of 3 quarters · filed 2015-03-02
$52.15M
10-K · filed 2015-03-02
2012-09-30$13.04M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08
$26.05M
derived: sum of 2 quarters · filed 2013-11-08
$39.12M
10-Q · filed 2013-11-08
$43.81M
derived: sum of 4 quarters · filed 2015-03-02
2012-06-30$13.01M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09
$26.08M
10-Q · filed 2013-08-09
$30.77M
derived: sum of 3 quarters · filed 2015-03-02
$34.68M
derived: sum of 4 quarters · filed 2015-03-02
2012-03-31$13.07M
10-Q · filed 2013-05-10
$17.75M
derived: sum of 2 quarters · filed 2015-03-02
$21.67M
derived: sum of 3 quarters · filed 2015-03-02
$25.32M
derived: sum of 4 quarters · filed 2015-03-02
2011-12-31$4.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
$8.60M
derived: sum of 2 quarters · filed 2015-03-02
$12.25M
derived: sum of 3 quarters · filed 2015-03-02
$15.25M
10-K · filed 2015-03-02
2011-09-30$3.92M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08
$7.57M
derived: sum of 2 quarters · filed 2012-11-08
$10.56M
10-Q · filed 2012-11-08
$13.58M
derived: sum of 4 quarters · filed 2013-03-01
2011-06-30$3.65M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09
$6.64M
10-Q · filed 2012-08-09
$9.66M
derived: sum of 3 quarters · filed 2013-03-01
$12.82M
derived: sum of 4 quarters · filed 2013-03-01
2011-03-31$2.99M
10-Q · filed 2012-05-08
$6.01M
derived: sum of 2 quarters · filed 2013-03-01
$9.17M
derived: sum of 3 quarters · filed 2013-03-01
$12.71M
derived: sum of 4 quarters · filed 2013-03-01
2010-12-31$3.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01
$6.18M
derived: sum of 2 quarters · filed 2013-03-01
$9.72M
derived: sum of 3 quarters · filed 2013-03-01
$13.31M
10-K · filed 2013-03-01
2010-09-30$3.16M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09
$6.70M
derived: sum of 2 quarters · filed 2011-11-09
$10.29M
10-Q · filed 2011-11-09
2010-06-30$3.54M
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09
$7.13M
10-Q · filed 2011-08-09
2010-03-31$3.60M
10-Q · filed 2011-05-10
2009-12-31$14.50M
10-K · filed 2012-02-28